NCT00660504 2014-07-18Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung CancerSumitomo Pharma (Suzhou) Co., Ltd.Phase 3 Completed300 enrolled 10 charts